Market Overview:
The global phenytoin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of seizures, rising geriatric population, and growing demand for anti-arrhythmic drugs. However, the high cost of phenytoin and stringent regulatory approvals are restraining the growth of this market. On the basis of type, tablets accounted for a larger share of the global phenytoin market in 2017. This can be attributed to their easy availability and low cost as compared to other forms such as injections. On the basis of application, seizures accounted for a major share of the global phenytoin market in 2017. This can be attributed to increasing incidence rates worldwide due to various factors such as aging population and lifestyle changes resulting in neurological disorders such as epilepsy seizure disorder .
Product Definition:
Phenytoin is an anticonvulsant drug used to prevent and treat seizures. It is also used to prevent migraine headaches.
Tablets:
Phenytoin is a type of epilepsy medication. It's main function is to prevent seizures by keeping them from happening. There are two ways in which it works; through the creation of an electrical barrier between the brain and nerve cells that would normally fire and through suppressing the neural signals before they reach the nerve cells.
Injection:
Injection is a medical procedure used to treat diseases by introducing the drug at the target site. The most common way of drug delivery is through injections, also known as syringes. Injections are widely used for the treatment of Phenytoin (Phenytoin), and it's one of the most commonly prescribed antiseizure drugs across all age groups in both developed and developing countries.
Application Insights:
The phenytoin market is segmented based on application into seizures, anti-arrhythmic, others and unknwon. Seizures held the largest revenue share in 2017 owing to high usage in epilepsy treatment. Phenytoin is an effective anticonvulsant medication that prevents brain damage caused by lack of oxygen during epileptic seizures. Epilepsy is a chronic neurological disease characterized by unpredictable recurrent attacks & symptoms such as convulsions, speech disorders and vision problems among many others. According to WHO, approximately 50 million people are suffering from epilepsy worldwide with around 2 million new cases being diagnosed every year globally till 2016 which was a major factor contributing towards large market share for this segment over the forecast period.
Regional Analysis:
North America phenytoin market dominated the global industry in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to rising product consumption, increasing number of generic manufacturers and availability of approved phenytoin products by healthcare practitioners in this region.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising disposable income, improving healthcare infrastructure and expansion of retail pharmacies in emerging countries such as China & India & Japan etc. Growing medical tourism industry due to low cost treatment options offered by these countries will also boost demand for various epilepsy drugs including Phenytoin sodium tablets over the coming years.
Moreover, growing awareness about epilepsy treatment options among patients from developed economies such as U.S.
Growth Factors:
- Increasing incidence of seizures and epilepsy: The major growth driver for the phenytoin market is the increasing incidence of seizures and epilepsy. According to a study by the World Health Organization, it is estimated that around 50 million people suffer from epilepsy worldwide, which is expected to increase to more than 75 million by 2030. This will create a high demand for phenytoin and other antiepileptic drugs (AEDs) in the coming years.
- Rising awareness about seizure disorders: There is a growing awareness among people about seizure disorders and their treatment options, including AEDs such as phenytoin. This has led to an increase in the number of patients seeking treatment for seizures, thereby driving demand for this drug.
- Growing population of elderly people: The population of elderly people is growing at a rapid pace across the world due to advances in medical care and healthcare facilities available today. As this population segment is more prone to developing seizure disorders, there will be an increased demand for phenytoin and other AEDs in the coming years catering to their needs specifically..
Scope Of The Report
Report Attributes
Report Details
Report Title
Phenytoin Market Research Report
By Type
Tablets, Injection
By Application
Seizures, Anti-Arrhythmic, Others
By Companies
Actavis mid atlantic llc, Pfizer pharmaceuticals ltd, Sun pharmaceutical industries ltd, Wockhardt ltd, Watson laboratories inc, Pharmeral inc, App pharmaceuticals llc, Baxter healthcare corp, Hospira inc, Warner chilcott div warner lambert co, Mylan pharmaceuticals inc, Pliva inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Phenytoin Market Report Segments:
The global Phenytoin market is segmented on the basis of:
Types
Tablets, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Seizures, Anti-Arrhythmic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Actavis mid atlantic llc
- Pfizer pharmaceuticals ltd
- Sun pharmaceutical industries ltd
- Wockhardt ltd
- Watson laboratories inc
- Pharmeral inc
- App pharmaceuticals llc
- Baxter healthcare corp
- Hospira inc
- Warner chilcott div warner lambert co
- Mylan pharmaceuticals inc
- Pliva inc
Highlights of The Phenytoin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Injection
- By Application:
- Seizures
- Anti-Arrhythmic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phenytoin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Phenytoin is a medication used to treat seizures. It is also used to prevent or reduce the severity of seizures in people with epilepsy. Phenytoin works by decreasing the activity of certain nerve cells in the brain that may cause seizures.
Some of the major companies in the phenytoin market are Actavis mid atlantic llc, Pfizer pharmaceuticals ltd, Sun pharmaceutical industries ltd, Wockhardt ltd, Watson laboratories inc, Pharmeral inc, App pharmaceuticals llc, Baxter healthcare corp, Hospira inc, Warner chilcott div warner lambert co, Mylan pharmaceuticals inc, Pliva inc.
The phenytoin market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Phenytoin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Phenytoin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Phenytoin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Phenytoin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Phenytoin Market Size & Forecast, 2018-2028
4.5.1 Phenytoin Market Size and Y-o-Y Growth
4.5.2 Phenytoin Market Absolute $ Opportunity
Chapter 5 Global Phenytoin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Phenytoin Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Phenytoin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Phenytoin Market Size Forecast by Applications
6.2.1 Seizures
6.2.2 Anti-Arrhythmic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Phenytoin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Phenytoin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Phenytoin Analysis and Forecast
9.1 Introduction
9.2 North America Phenytoin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Phenytoin Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Phenytoin Market Size Forecast by Applications
9.10.1 Seizures
9.10.2 Anti-Arrhythmic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Phenytoin Analysis and Forecast
10.1 Introduction
10.2 Europe Phenytoin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Phenytoin Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Phenytoin Market Size Forecast by Applications
10.10.1 Seizures
10.10.2 Anti-Arrhythmic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Phenytoin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Phenytoin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Phenytoin Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Phenytoin Market Size Forecast by Applications
11.10.1 Seizures
11.10.2 Anti-Arrhythmic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Phenytoin Analysis and Forecast
12.1 Introduction
12.2 Latin America Phenytoin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Phenytoin Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Phenytoin Market Size Forecast by Applications
12.10.1 Seizures
12.10.2 Anti-Arrhythmic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Phenytoin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Phenytoin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Phenytoin Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Phenytoin Market Size Forecast by Applications
13.10.1 Seizures
13.10.2 Anti-Arrhythmic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Phenytoin Market: Competitive Dashboard
14.2 Global Phenytoin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Actavis mid atlantic llc
14.3.2 Pfizer pharmaceuticals ltd
14.3.3 Sun pharmaceutical industries ltd
14.3.4 Wockhardt ltd
14.3.5 Watson laboratories inc
14.3.6 Pharmeral inc
14.3.7 App pharmaceuticals llc
14.3.8 Baxter healthcare corp
14.3.9 Hospira inc
14.3.10 Warner chilcott div warner lambert co
14.3.11 Mylan pharmaceuticals inc
14.3.12 Pliva inc
